Sangu Delle
Chairman & CEO @ Golden Palm Investments
New York, United States
Sangu Delle is a seed investor at Golden Palm Investments in New York focused on Health Care and B2B. Sangu Delle - Managing Director & Co-founder @ Africa Health Holdings Ltd
- Total investments:
- 8
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Sangu Delle invests in
Stages Sangu Delle invests in
Countries Sangu Delle invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $230k–$5M
- Series A
- $6.6M–$14M
Investment Focus
Industry
- Health Care 2 (25%)
- B2B 1 (13%)
- FinTech 1 (13%)
- Hospital 1 (13%)
- Internet 1 (13%)
Stage
- Seed 2 (25%)
- Series A 2 (25%)
- Series B 1 (13%)
- Series C 1 (13%)
- Convertible Note 1 (13%)
Country
- Ghana 2 (25%)
- United States 2 (25%)
- Germany 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Africa Health Holdings Ltd
|
Africa Health Holdings cultivates a work-environment that motivates professionals to strive to exceed their expectations. It offers a variety of exciting and challenging careers across Africa and North America. It values teamwork and the enthusiasm to become a contributor to the development and success of local communities across Africa.It wasfounded in 2017 and is headquartered in Accra, Ghana with offices in Nigeria and New York. | $10M / Convertible Note / May 17, 2022 | |
Frontier Car Group
|
Frontier Car Group is a berlin-based startup who develop, launch, and operate used-automotive marketplaces within emerging market economies, with operations in Nigeria, Mexico, Argentina, Colombia, Chile, Pakistan, and Indonesia. Additionally, we are successfully engaging in two joint ventures with OLX in India and Poland. We increase theefficiency of selling and buying cars through technology, infra-structure creation, access to capital and innovative business models that allows all stakeholders to gain from our impact. | $41M / Series B / Mar 29, 2018 | |
mPharma
|
mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. It aims to increase patient access to high-quality medications. mPharma partners with drug manufacturers, insurance companies, financial institutions, and governments to deliver prescription drugs directly toconsumers in emerging markets. They provide doctors, patients, and pharmacists access to a network of high-quality chronic disease medicine at sustainable prices.The company was founded by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) in 2013. | $6.6M / Series A / Nov 23, 2017 | |
Andela
|
Andela operates the world’s largest private marketplace of skilled digital talent. Its adaptive hiring model gives companies greater flexibility to quickly deploy skilled talent based on need. The company’s exclusive AI-powered platform, Andela Talent Cloud, optimizes the process of finding the right talent and getting projects started fast.Clients can select individual roles or engage fully managed teams up to 66% faster at 30-50% less cost than traditional approaches. Andela’s seasoned hiring professionals manage all the groundwork associated with borderless hiring, from compliance and payroll to talent management. Andela’s diverse talent ecosystem spans over 135 countries, including untapped markets like Africa and Latin America, and is highly skilled in advanced technologies to support Application Development,Artificial Intelligence, Cloud & DevOps, Data Engineering, and more. | $40M / Series C / Oct 10, 2017 | |
Flutterwave
|
Flutterwave provides a payment infrastructure for merchants and payment service providers. They offer an online marketplace for businesses to list their products and services for sale. They provide payment tools, including a smart payment ordering system for businesses to accept payments. | $230K / Seed / Aug 23, 2016 | |
|
mPharma
|
mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. It aims to increase patient access to high-quality medications. mPharma partners with drug manufacturers, insurance companies, financial institutions, and governments to deliver prescription drugs directly toconsumers in emerging markets. They provide doctors, patients, and pharmacists access to a network of high-quality chronic disease medicine at sustainable prices.The company was founded by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) in 2013. | $5M / Seed / Jan 28, 2016 | |
|
mPharma
|
mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. It aims to increase patient access to high-quality medications. mPharma partners with drug manufacturers, insurance companies, financial institutions, and governments to deliver prescription drugs directly toconsumers in emerging markets. They provide doctors, patients, and pharmacists access to a network of high-quality chronic disease medicine at sustainable prices.The company was founded by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) in 2013. | Seed / Dec 01, 2015 | |
|
Andela
|
Andela operates the world’s largest private marketplace of skilled digital talent. Its adaptive hiring model gives companies greater flexibility to quickly deploy skilled talent based on need. The company’s exclusive AI-powered platform, Andela Talent Cloud, optimizes the process of finding the right talent and getting projects started fast.Clients can select individual roles or engage fully managed teams up to 66% faster at 30-50% less cost than traditional approaches. Andela’s seasoned hiring professionals manage all the groundwork associated with borderless hiring, from compliance and payroll to talent management. Andela’s diverse talent ecosystem spans over 135 countries, including untapped markets like Africa and Latin America, and is highly skilled in advanced technologies to support Application Development,Artificial Intelligence, Cloud & DevOps, Data Engineering, and more. | $14M / Series A / Jun 25, 2015 |
Co-Investors
About Golden Palm Investments
Golden Palm Investments is an impact investment firm that invests in early-stage, venture, and growth capital in Africa. It focuses on real-estate, agribusiness, and technology and specializes in investment management and investment advisory. Golden Palm Investments was founded in 2008 and headquartered in Accra, Greater Accra.
Golden Palm Investments Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alex Marlantes
Partner
|
|||
|
Bangu Delle
Partner
|
|||
Brandon Arrindell
Partner
|
|||
Erharuyi Idemudia
Partner, General Counsel
|
|||
|
Sangu Delle
Chairman & CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sangu Delle invest in?
Sangu Delle invests primarily in Health Care, B2B and FinTech startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in Ghana. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sangu Delle's check size?
Sangu Delle typically joins rounds of $230k–$5M at Seed and $6.6M–$14M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sangu Delle participates in.
How do I contact Sangu Delle?
Public channels for Sangu Delle include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sangu Delle last invest?
The most recent investment recorded for Sangu Delle closed in May 2022. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
